Hensley Mark Earl
CIK: 0002065816•Chief Operating Officer
Officer
Primary company: HERON THERAPEUTICS, INC. /DE/ (HRTX)
Hensley Mark Earl is a corporate insider (Chief Operating Officer) at HERON THERAPEUTICS, INC. /DE/ (HRTX) filing SEC Form 4 transactions. 12 transactions. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 31,250 | - | - | 343,750 | 8/6/2026 Filed: 8/6/2026 | Filing → | |
| Tax Payment | 8,888 | $0.50 | $4K | 170,901 | 8/6/2026 Filed: 8/6/2026 | Filing → | |
| Exercise | 31,250 | - | - | 179,789 | 8/6/2026 Filed: 8/6/2026 | Filing → | |
| Exercise | 11,769 | - | - | 164,776 | 7/31/2026 Filed: 7/31/2026 | Filing → | |
| Exercise | 11,769 | - | - | 148,539 | 7/31/2026 Filed: 7/31/2026 | Filing → | |
| Exercise | 125,000 | - | - | 375,000 | 5/6/2026 Filed: 5/6/2026 | Filing → | |
| Exercise | 125,000 | - | - | 136,770 | 5/6/2026 Filed: 5/6/2026 | Filing → | |
| Exercise | 11,770 | - | - | 176,545 | 4/30/2026 Filed: 4/30/2026 | Filing → | |
| Exercise | 11,770 | - | - | 11,770 | 4/30/2026 Filed: 4/30/2026 | Filing → | |
| Award | 188,314 | - | - | 188,314 | 1/30/2026 Filed: 1/30/2026 | Filing → | |
| Award | 188,315 | - | - | 188,315 | 1/30/2026 Filed: 1/30/2026 | Filing → | |
| Award | 500,000 | - | - | 500,000 | 5/6/2025 Filed: 5/7/2025 | Filing → |
Type
Exercise
Shares
31,250
Price
-
Value
-
Type
Tax Payment
Shares
8,888
Price
$0.50
Value
$4K
Type
Exercise
Shares
31,250
Price
-
Value
-
Type
Exercise
Shares
11,769
Price
-
Value
-
Type
Exercise
Shares
11,769
Price
-
Value
-
Type
Exercise
Shares
125,000
Price
-
Value
-
Type
Exercise
Shares
125,000
Price
-
Value
-
Type
Exercise
Shares
11,770
Price
-
Value
-
Type
Exercise
Shares
11,770
Price
-
Value
-
Type
Award
Shares
188,314
Price
-
Value
-
Type
Award
Shares
188,315
Price
-
Value
-
Type
Award
Shares
500,000
Price
-
Value
-
AI Agent
Try asking...